New Combo Therapy Extends Survival By More Than A Year In Advanced Triple Positive Breast Cancers

WEDNESDAY, Feb. 4, 2026— Taking one additional pill could buy more than an extra year of precious time for people with advanced breast cancer, a new clinical trial showed.Adding the targeted drug palbociclib (Ibrance) to existing therapies added 1...